已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Exploring the vast potentials and probable limitations of novel and nanostructured implantable drug delivery systems for cancer treatment

药物输送 药品 癌症治疗 癌症 癌症治疗 医学 自愈水凝胶 纳米技术 药理学 生物医学工程 化学 材料科学 内科学 有机化学
作者
Maryam Ebrahimnia,Sonia Alavi,Hamed Vaezi,Mahdieh Karamat Iradmousa,Azadeh Haeri
出处
期刊:Excli Journal [IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund]
卷期号:23: 143-179 被引量:10
标识
DOI:10.17179/excli2023-6747
摘要

Conventional cancer chemotherapy regimens, albeit successful to some extent, suffer from some significant drawbacks, such as high-dose requirements, limited bioavailability, low therapeutic indices, emergence of multiple drug resistance, off-target distribution, and adverse effects. The main goal of developing implantable drug delivery systems (IDDS) is to address these challenges and maintain anti-cancer drugs directly at the intended sites of therapeutic action while minimizing inevitable side effects. IDDS possess numerous advantages over conventional drug delivery, including controlled drug release patterns, one-time drug administration, as well as loading and stabilizing poorly water-soluble chemotherapy drugs. Here, we summarized conventional and novel (three-dimensional (3D) printing and microfluidic) preparation techniques of different IDDS, including nanofibers, films, hydrogels, wafers, sponges, and osmotic pumps. These systems could be designed with high biocompatibility and biodegradability features using a wide variety of natural and synthetic polymers. We also reviewed the published data on these systems in cancer therapy with a particular focus on their release behavior. Various release profiles could be attained in IDDS, which enable predictable, adjustable, and sustained drug releases. Furthermore, multi-step or stimuli-responsive drug release could be obtained in these systems. The studies mentioned in this article have proven the effectiveness of IDDS for treating different cancer types with high prevalence, including breast cancer, and aggressive cancer types, such as glioblastoma and liver cancer. Additionally, the challenges in applying IDDS for efficacious cancer therapy and their potential future developments are also discussed. Considering the high potential of IDDS for further advancements, such as programmable release and degradation features, further clinical trials are needed to ensure their efficiency. The overall goal of this review is to expand our understanding of the behavior of commonly investigated IDDS and to identify the barriers that should be addressed in the pursuit of more efficient therapies for cancer. See also the graphical abstract(Fig. 1).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
淡淡的志泽完成签到,获得积分10
2秒前
2秒前
3秒前
3921337477的应助被u181800采纳,获得60
3秒前
3秒前
言_完成签到 ,获得积分10
3秒前
5秒前
热爱学习发布了新的文献求助10
5秒前
小鹿不迷路完成签到 ,获得积分10
8秒前
热爱学习发布了新的文献求助10
8秒前
热爱学习发布了新的文献求助30
9秒前
dd发布了新的文献求助30
11秒前
13秒前
仁爱的觅海完成签到,获得积分10
13秒前
u181800发布了新的文献求助60
15秒前
zhongxia完成签到 ,获得积分10
16秒前
3921337477的应助被u831685采纳,获得60
20秒前
xiaojunsong完成签到 ,获得积分10
21秒前
21秒前
23秒前
曲聋五完成签到 ,获得积分0
24秒前
25秒前
炙热问芙完成签到,获得积分20
25秒前
26秒前
SciGPT的应助被yao采纳,获得10
27秒前
moriaty发布了新的文献求助20
28秒前
Rebirth发布了新的文献求助10
31秒前
u831685发布了新的文献求助60
33秒前
molihuakai的应助被007采纳,获得10
33秒前
33秒前
GingerF的应助被DW采纳,获得50
33秒前
Orange的应助被yayayang采纳,获得10
33秒前
政瞳完成签到,获得积分20
36秒前
美味又健康完成签到 ,获得积分10
37秒前
3921337477的应助被u661398采纳,获得60
37秒前
38秒前
39秒前
冬月初七完成签到 ,获得积分10
39秒前
123完成签到,获得积分10
39秒前
kali发布了新的文献求助200
42秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184917
求助须知:如何正确求助?哪些是违规求助? 9573843
关于积分的说明 21833352
捐赠科研通 7782304
什么是DOI,文献DOI怎么找? 3434429
关于科研通互助平台的介绍 2558581
邀请新用户注册赠送积分活动 2481082